Benefits of Alcoholic Hangover Medicine
BLAM
1 other identifier
interventional
2
1 country
1
Brief Summary
Myrkl is advertised as a dietary supplement for use before alcohol consumption that is effective in prevention of side effects during the next day. With this research, the investigators want to determine the impact of the mentioned dietary supplement on the intestinal microbiome. For this purpose, the research was designed in three phases before, during and after the research as a double blind trial. In doing so, the subjects take a stool sample before and after the intervention and during the intervention, fill out questionnaires and undergo cognitive tests. At the same time, they give a blood sample after the intervention. After the results of the analysis are due, the researchers enter the data into the for that the predicted Access table (rel. representation of genera/genera/species, average results by questionnaires). The entered data is processed as part of statistical analysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 31, 2023
CompletedStudy Start
First participant enrolled
October 31, 2023
CompletedFirst Posted
Study publicly available on registry
November 13, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2023
CompletedNovember 13, 2023
October 1, 2023
1 month
October 31, 2023
November 8, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Gut microbiome composition
The impact of Myrkl on gut microbiome shall assessed through monitoring of relative taxonomic abundance of bacteria that compose gut microbiota from samples taken day before the intervention and after the intervention. The composition of the intestinal microbiota will be determined by sequencing the 16s rRNA bacteria in the stool sample. Subjects take a sample with a sterile cotton swab by wiping stool with toilet paper in their home on a given day research. The sample is stored in a tube with a buffer liquid so that the sample can be stored and transported at room temperature temperature. The test sample is transported by air to the laboratory of Biomes NGS Gesellschaft mit beschränkter Haftung, Wildau, Germany.
one month
Secondary Outcomes (1)
the subjective impression of a hangover
one month
Other Outcomes (1)
other approach of impression of a hangover
one month
Study Arms (2)
Probiotic
EXPERIMENTALParticipants will consume 800 mg of probiotic Myrkl before consuming alcohol in the form of one capsule. (Myrkl, De Fair Medical, Stockholm, Sweden). This formulation contains AB001™, and one capsule (800mg) consists of: * 560 mg of naturally fermented rice bran * Bacillus subtilis * B. coagulans * L-cysteine * dextrin * 36 mg of excipients: magnesium stearate salts, calcium phosphate, potassium phosphate
Placebo
EXPERIMENTALThe subject who consumed 800 mg of placebo- dextrin (maltodextrin) in the form of two capsules before consuming alcohol.
Interventions
The subject of the test will be supplementation with precise probiotic for hangovers (Myrkl, De Fair) in the form of one pill of 800 mg
The subject of the test will be supplementation with placebo (maltodextrin) in the form of two pills (each 400 mg)
Eligibility Criteria
You may qualify if:
- fraternal twins who live and work together
You may not qualify if:
- consumption of other probiotics, antibiotics 30 days before the research
- Inability to drink alcohol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gut Microbiome Center
Zagreb, 10000, Croatia
Related Links
- Chronic Uptake of A Probiotic Nutritional Supplement (AB001) Inhibits Absorption of Ethylalcohol in the Intestine Tract - Results from a Randomized Double-blind Crossover Study
- Chronic Uptake of A Probiotic Nutritional Supplement (AB001) Inhibits Absorption of Ethylalcohol in the Intestine Tract - Results from a Randomized Double-blind Crossover Study
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Andrija Karačić, dr.med
Centar za crijevni mikrobiom
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- The test subjects receive capsules of probiotics and palceb in marked bags and take one or the other arbitrarily without being told what is in which bag. Likewise, the researchers do not know whether the subjects took the probiotic or the placebo
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 31, 2023
First Posted
November 13, 2023
Study Start
October 31, 2023
Primary Completion
December 1, 2023
Study Completion
December 20, 2023
Last Updated
November 13, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share